Skip to Content
Merck
All Photos(2)

Key Documents

MAB1976

Sigma-Aldrich

Anti-Integrin αVβ3 Antibody, clone LM609

clone LM609, Chemicon®, from mouse

Synonym(s):

Vitronectin Receptor, CD51/CD61

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

affinity purified immunoglobulin

antibody product type

primary antibodies

clone

LM609, monoclonal

species reactivity

chicken, canine, rabbit, avian, monkey, human, pig, bovine

should not react with

mouse, rat

manufacturer/tradename

Chemicon®

technique(s)

flow cytometry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
immunoprecipitation (IP): suitable

isotype

IgG1

suitability

not suitable for immunohistochemistry (Paraffin)

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... ITGAV(3685)

Related Categories

General description

The integrin family of cell adhesion receptors consists of at least 16 membrane-associated heterodimers, composed of an alpha and beta subunit that associate in a non-covalent manner. The structure and functional diversity of the integrin family are based upon the pairing abilities of the individual alpha and beta subunits. Key to these molecular interactions between the integrin receptors and their respective ligands is the recognition of the Arg-Gly-Asp (RGD) sequence, known to be present in the extracellular matrix components fibronectin, vitronectin, collagen, fibrinogen, and von Willebrand factor (Cheresh, 1991). The involvement of integrins in vascular proliferation, adhesion, and wound repair has been well documented. The adhesion receptor, integrin alphaVbeta3, appears to be selectively expressed on growing blood vessels and has been identified as a marker of angiogenic vascular tissue (Brooks, 1994). Due to its involvement in angiogenesis, integrin alphaVbeta3 is one of the most intensely studied of the integrin receptors..

Specificity

Reacts with the vitronectin receptor alphaVbeta3 complex, an RGD-directed adhesion receptor. LM609 has been demonstrated to block adhesion of a human melanoma cell line (M21) to vitronectin, fibrinogen and von Willebrand factor, as well as to a synthetic RGD containing peptide (Cheresh, 1987). In chick chorioallentoic membranes, LM609 was shown to block angiogenesis induced by bFGF and TNFalpha but had no effect on pre-existing vessels (Brooks, 1994). While LM609 does block cell attachment to RGD containing ligands, it does not interact directly with the RGD binding site. Instead, LM609 appears to be an allosteric inhibitor of integrin alphaVbeta3, which binds to a conformational epitope resulting from the post-translational association of the alphaV and beta3 subunits.

Immunogen

Purified adhesion receptor from the human melanoma cell line M21 (Cheresh, 1987).

Application

Anti-Integrin αVβ3 Antibody, clone LM609 is an antibody against Integrin αVβ3 for use in FC, IF, IH and IP and has published in over 60 citations.
Flow Cytometry: 1-3 μg LM609 per 0.5 x 10e6 cells in 100μL (Smith, 1996).

Immunoprecipitation: specifically immunoprecipitates the integrin alphaVbeta3 complex which, when resolved by SDS-PAGE under reducing conditions, results in an approximately 130 kDa band corresponding to the alphaV subunit and a 105 kDa band corresponding to the beta3 subunit (Cheresh, 1987).

Immunofluorescence: 5-10 μg/mL for staining of bFGF-treated 6 mm cryosections of chick chorioallantoic membrane fixed with acetone (Brooks, 1994). LM609 is also effective on 4% paraformaldehyde fixed, frozen tissues and cells. However it is not effective for immunohistochemical staining of paraffin-embedded tissue sections.

Inhibits adhesion of cells to vitronectin coated surfaces at 10-25 μg/mL.

Optimal working dilutions and protocols must be determined by end user.
Research Category
Cell Structure
Research Sub Category
Integrins

Target description

150 kDa

Physical form

Format: Purified
Immunoglobulin was Purified by protein A affinity and is presented as a liquid in 0.02M PB, pH 7.6, 0.25M NaCl containing 0.1% sodium azide.
Protein A purified

Storage and Stability

Maintain for 1 year at 2–8°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Positive Control: Human myeloma cell lines M21 and MoαV (Chen, 1995).
Negative Control: Mo cells (this cell line was derived from M21 but does not express integrin αV

Chen, 1995)

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia
Rosenberg, N. et al.
Journal of Thrombosis and Haemostasis, 3(12), 2764-2772 (2005)
Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers.
Raymond, T; Gorbunova, E; Gavrilovskaya, IN; Mackow, ER
Proceedings of the National Academy of Sciences of the USA null
Selective replicating viral vectors : potential for use in cancer gene therapy.
John Nemunaitis
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy null
Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation.
S Pons, J L Trejo, J R Martinez-Morales, E Marti
Development null
Disruption of the beta3 663-687 disulfide bridge confers constitutive activity to beta3 integrins.
Butta, N; Arias-Salgado, EG; Gonzalez-Manchon, C; Ferrer, M; Larrucea, S; Ayuso, MS; Parrilla, R
Blood null

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service